ENANTA PHARMACEUTICALS INC Annual Net Income (Loss) Attributable to Parent in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Enanta Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2023.
  • Enanta Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$22.7M, a 42% increase year-over-year.
  • Enanta Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$115M, a 12.7% increase year-over-year.
  • Enanta Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$134M, a 9.91% decline from 2022.
  • Enanta Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$122M, a 54.1% decline from 2021.
  • Enanta Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$79M, a 118% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$134M -$12.1M -9.91% Oct 1, 2022 Sep 30, 2023 10-Q 2024-08-07
2022 -$122M -$42.8M -54.1% Sep 30, 2021 Sep 30, 2022 10-Q 2023-02-08
2021 -$79M -$42.8M -118% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-22
2020 -$36.2M -$82.6M -178% Oct 1, 2019 Sep 30, 2020 10-K 2022-11-23
2019 $46.4M -$25.6M -35.5% Oct 1, 2018 Sep 30, 2019 10-K 2021-11-24
2018 $72M +$54.2M +306% Oct 1, 2017 Sep 30, 2018 10-K 2020-11-25
2017 $17.7M -$3.96M -18.3% Oct 1, 2016 Sep 30, 2017 10-K 2019-11-27
2016 $21.7M -$57.3M -72.6% Oct 1, 2015 Sep 30, 2016 10-K 2018-11-29
2015 $79M +$44.6M +129% Oct 1, 2014 Sep 30, 2015 10-K 2017-12-11
2014 $34.4M +$24.8M +258% Oct 1, 2013 Sep 30, 2014 10-K 2016-12-09
2013 $9.63M -$11.8M -55% Oct 1, 2012 Sep 30, 2013 10-K 2015-12-11
2012 $21.4M -$1.91M -8.2% Oct 1, 2011 Sep 30, 2012 10-K 2014-12-11
2011 $23.3M Oct 1, 2010 Sep 30, 2011 10-K 2013-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.